ArticleFrontiers in pharmacology2021

Ruxolitinib in Patients With Chronic Active Epstein-Barr Virus Infection: A Retrospective, Single-Center Study.

Yue Song et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.